The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
944
March 17, 1995
View Complete Issue         Table of Contents 2019 
Lamotrigine For Epilepsy
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Lamotrigine For Epilepsy
March 17, 1995 (Issue: 944)
Lamotrigine (la mo tri jeen; Lamictal - Burroughs Wellcome), a phenyltriazine derivative, has been approved by the US Food and Drug Administration for use in addition to other antiepileptic drugs in adults with partial seizures. Since this...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Lamotrigine For Epilepsy
Article code: 944a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.